Showing results (821-830 of 2,003) with videos related to

Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|April 9, 2008
Possible roles of reg family proteins in pancreatic islet cell growthJun-Li Liu, Wei Cui, Bing Li, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 17, 2018
Diabetes Association with Liver Diseases: An Overview for CliniciansAbd Elkhalek Hamed, Nadia Elwan, Mervat Naguib, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 3, 2018
Hypothyroidism Alters the Uterine Lipid Levels in Pregnant Rabbits and Affects the Fetal SizeJulia Rodríguez-Castelán, Dafne Zepeda-Pérez, Maribel Méndez-Tepepa, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 30, 2019
The Pleiotropic Effects of Statins in Endocrine DisordersJavier A De La Cruz, Christos G Mihos, Sofia A Horvath, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 20, 2019
SRC-3/AIB-1 may Enhance Hepatic NFATC1 Transcription and Mediate Inflammation in a Tissue-Specific Manner in Morbid ObesityAthina Chasapi, Konstantinos Balampanis, Anna Tanoglidi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 20, 2019
Differential Expression of MARK4 Protein and Related Perturbations in Females with Ovulatory PCOSAhmad Fazilat, Nadia Rashid, Aruna Nigam, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 28, 2019
Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced ObesityFanqing Meng, Dongliang Li, Bingfeng Song, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 27, 2018
Probiotics for Gastrointestinal and Liver Diseases: An Updated Review of the Published LiteratureFrancis E Dailey, Erica P Turse, Brett Rossow, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 27, 2018
The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is ManufacturedPaola Palumbo, Francesca Lombardi, Maria Grazia Cifone, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 8, 2019
Pain and Muscles Properties Modifications After Botulinum Toxin Type A (BTX-A) and Radial Extracorporeal Shock Wave (rESWT) Combined TreatmentMarisa Megna, Riccardo Marvulli, Giacomo Farì, et al.
Pageof 201